Topic Hub
50 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 50 of 50 clinical reviews.
A clinical guide to acute insomnia covering diagnosis, first-line cognitive behavioral therapy, FDA-approved medications, and related sleep disorders including obstructive sleep apnea, restless legs syndrome, and periodic limb movement disorder.
Read clinical reviewA clinician-reviewed comparison of Ambien (zolpidem) vs Lunesta (eszopiclone), plus trazodone, mirtazapine, DORAs, melatonin, ramelteon, and CPAP vs oral appliances for sleep disorders.
Read clinical reviewNightly Ambien (zolpidem) use carries real risks of tolerance, dependence, and next-day impairment. Learn what the FDA, clinical trials, and sleep-medicine guidelines say about safe duration, safer alternatives, and how to taper off.
Read clinical reviewA clinician-reviewed guide to chronic insomnia covering CBT-I, pharmacotherapy, sleep apnea, restless legs syndrome, and when to seek specialist care.
Read clinical reviewA physician-reviewed guide to circadian rhythm disorders, covering DSPD, ASPD, shift-work disorder, obstructive sleep apnea, restless legs syndrome, chronic and acute insomnia, with current diagnostic criteria, named trials, real doses, and evidence-based treatment protocols.
Read clinical reviewA comprehensive breakdown of sleep medication costs, from older generics like temazepam to newer dual orexin receptor antagonists like suvorexant and lemborexant, including insurance coverage tips and out-of-pocket strategies.
Read clinical reviewA clinician-reviewed comparison of CPAP therapy and mandibular advancement devices for obstructive sleep apnea, plus how sleep medications like zolpidem, eszopiclone, trazodone, mirtazapine, suvorexant, and ramelteon fit into a complete sleep-medicine plan.
Read clinical reviewA clinician-reviewed guide to daridorexant (Quviviq) covering mechanism, dosing, clinical trial data, and head-to-head comparisons with zolpidem, eszopiclone, zaleplon, and melatonin for chronic insomnia.
Read clinical reviewDiscontinuation insomnia is the rebound wakefulness that follows stopping sedative-hypnotic drugs. Learn which agents cause it, how long it lasts, and what evidence-based strategies minimize it.
Read clinical reviewA clinician-reviewed look at whether CBD improves sleep, how it compares to melatonin, Ambien, and trazodone, and what doses the current evidence supports.
Read clinical reviewA physician-reviewed comparison of dual orexin receptor antagonists (suvorexant, lemborexant), Z-drugs (zolpidem, eszopiclone, zaleplon), trazodone, ramelteon, and melatonin for chronic insomnia. Covers efficacy data, abuse potential, next-day impairment, and who should get what.
Read clinical reviewA clinician-reviewed guide to doxepin (Silenor) for insomnia: mechanism, dosing, side effects, safety, and head-to-head comparisons with zolpidem, eszopiclone, zaleplon, and melatonin.
Read clinical reviewA clinician-reviewed guide to eszopiclone (Lunesta): FDA-approved doses, mechanism of action, side effects, drug interactions, and head-to-head comparisons with zolpidem (Ambien), zaleplon (Sonata), suvorexant (Belsomra), and melatonin.
Read clinical reviewA clinician-reviewed guide to gabapentin for sleep covering mechanism, dosing, evidence from named trials, side effects, and head-to-head comparisons with melatonin, zolpidem, eszopiclone, and zaleplon.
Read clinical reviewLearn the safe melatonin dose range, what counts as too much, signs of overdose, long-term safety data, and how melatonin compares to Ambien and trazodone for sleep.
Read clinical reviewA clinician-reviewed guide to insurance coverage for dual orexin receptor antagonists (DORAs) like suvorexant and lemborexant, including cost breakdowns, prior authorization requirements, and step-therapy protocols.
Read clinical reviewAmbien (zolpidem) carries real addiction and dependence risk. Learn what the FDA says, how nightly use changes your brain, and which evidence-backed alternatives, trazodone, melatonin, magnesium glycinate, may work instead.
Read clinical reviewA clinician-reviewed look at whether magnesium glycinate actually improves sleep, what the trials show, how it compares to melatonin, trazodone, and zolpidem, and how to use it safely.
Read clinical reviewA clinician-reviewed look at long-term melatonin safety, Ambien dependence risk, trazodone morning grogginess, and whether magnesium glycinate actually improves sleep, with doses, trial data, and FDA guidance.
Read clinical reviewREM sleep and deep sleep serve different but equally necessary functions. Learn what each stage does, how much you need, and what happens when either is disrupted.
Read clinical reviewA clinician-reviewed guide to lemborexant (Dayvigo) covering FDA-approved dosing, head-to-head data vs. zolpidem, eszopiclone, zaleplon, and melatonin, side effects, and who qualifies for a prescription.
Read clinical reviewA clinical comparison of melatonin and ramelteon for insomnia, including dosing, mechanism, safety, and how they stack up against Ambien, Lunesta, trazodone, mirtazapine, Belsomra, and CPAP therapy.
Read clinical reviewA physician-reviewed guide to melatonin covering optimal dosing, timing, side effects, drug interactions, and when prescription alternatives like zolpidem or suvorexant make more sense.
Read clinical reviewA clinician-reviewed guide to using mirtazapine for sleep: how it works, what doses are used off-label, trial data, and a head-to-head comparison with zolpidem, eszopiclone, zaleplon, and melatonin.
Read clinical reviewA clinician-reviewed guide to modafinil and armodafinil covering FDA-approved indications, dosing, pharmacokinetics, side effects, drug interactions, and how these wakefulness agents compare to zolpidem, eszopiclone, zaleplon, and melatonin.
Read clinical reviewLearn how narcolepsy type 1 and type 2 differ in symptoms, CSF hypocretin levels, diagnosis criteria, and FDA-approved treatments including sodium oxybate and pitolisant.
Read clinical reviewA clinician-reviewed guide to obstructive sleep apnea covering AHI thresholds, CPAP protocols, surgical options, and links to insomnia, restless legs syndrome, and periodic limb movement disorder.
Read clinical reviewA comprehensive clinical guide to periodic limb movement disorder (PLMD), covering diagnostic criteria, polysomnography thresholds, drug and non-drug treatments, and its relationship with restless legs syndrome, sleep apnea, and insomnia.
Read clinical reviewA clinical deep-dive into off-label quetiapine (Seroquel) for insomnia: how it works, what the evidence shows, safety risks at low doses, and how it compares to melatonin, zolpidem, eszopiclone, and zaleplon.
Read clinical reviewA clinician-reviewed guide to ramelteon (Rozerem): mechanism of action, 8 mg dosing, onset time, side effects, drug interactions, and head-to-head data vs. zolpidem, eszopiclone, zaleplon, and melatonin supplements.
Read clinical reviewA complete clinical guide to REM sleep behavior disorder (RBD): diagnostic criteria, polysomnography findings, link to neurodegeneration, and evidence-based treatment with clonazepam and melatonin.
Read clinical reviewA clinician-reviewed guide to restless legs syndrome (RLS): diagnostic criteria, dopaminergic and non-dopaminergic treatments, links to periodic limb movement disorder, sleep apnea, and chronic insomnia, plus when to escalate care.
Read clinical reviewShift work sleep disorder causes chronic insomnia and excessive sleepiness in night-shift and rotating-shift workers. Learn how clinicians diagnose it, which medications are approved, and what behavioral strategies reduce long-term risk.
Read clinical reviewEvidence-based strategies for shift workers, older adults, pregnant women, postmenopausal women, and travelers dealing with circadian misalignment, sleep loss, and jet lag.
Read clinical reviewBoard-reviewed guide covering sleep changes in older adults, postmenopausal women, pregnant patients, shift workers, and frequent travelers. Includes specific doses, trial data, and clinical protocols.
Read clinical reviewPostmenopausal women face unique sleep challenges driven by estrogen loss, hot flashes, and circadian changes. This evidence-based guide covers proven treatments, from menopausal hormone therapy to CBT-I, light therapy, and sleep hygiene tailored to older adults, shift workers, and travelers.
Read clinical reviewA clinician-reviewed guide to sleep medicine covering common disorders, diagnostic tools, first-line treatments including CBT-I and pharmacotherapy, and when to see a specialist.
Read clinical reviewEvidence-based guidance on managing sleep disorders across life stages and situations, including pregnancy, postmenopausal insomnia, older adults, shift workers, and jet-lag recovery protocols.
Read clinical reviewA clinician-reviewed guide to sodium oxybate (Xyrem) for narcolepsy, covering FDA-approved dosing, trial data, side effects, REMS requirements, and comparisons with melatonin, zolpidem, eszopiclone, and zaleplon.
Read clinical reviewA physician-reviewed guide to suvorexant (Belsomra) covering mechanism, FDA-approved dosing, head-to-head comparisons with zolpidem, eszopiclone, zaleplon, and melatonin, plus safety data from randomized controlled trials.
Read clinical reviewA clinical guide to how benzodiazepines, Z-drugs, and other sleep medications cause tolerance and physical dependence, with evidence-based tapering strategies and safer long-term alternatives.
Read clinical reviewA clinician-reviewed guide to jet lag covering causes, melatonin dosing, light therapy, medications, and special considerations for older adults, pregnant women, postmenopausal women, and shift workers.
Read clinical reviewA clinician-reviewed guide to trazodone as a sleep aid: how it works, what doses are used off-label, how it compares to zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), and melatonin, and who should and should not use it.
Read clinical reviewA clinician-reviewed guide to trazodone dosing for insomnia, covering starting doses, titration, maximum doses, drug interactions, and how it compares to Z-drugs.
Read clinical reviewA head-to-head clinical comparison of trazodone and mirtazapine for insomnia, covering doses, mechanisms, side-effect profiles, and how each compares to Ambien, Belsomra, ramelteon, and CPAP.
Read clinical reviewTrazodone causes grogginess because it blocks histamine H1 receptors and has a half-life of 5-9 hours, leaving sedating metabolites active into the morning. Learn how it compares to Ambien, melatonin, and magnesium glycinate.
Read clinical reviewZ-drugs like zolpidem, zaleplon, and eszopiclone can trigger complex sleep behaviors including sleepwalking, sleep-driving, and sleep-eating. Learn what the FDA says, how to recognize the risks, and when to stop.
Read clinical reviewComplete clinical guide to FDA-approved maximum doses for zolpidem, eszopiclone, and zaleplon, with trazodone off-label dosing for insomnia. Reviewed by the HealthRX.com medical team.
Read clinical reviewA clinician-reviewed guide to zaleplon (Sonata): FDA-approved doses, mechanism of action, side effects, drug interactions, and head-to-head comparisons with zolpidem, eszopiclone, suvorexant, and melatonin.
Read clinical reviewA clinician-reviewed guide to zolpidem (Ambien): how it works, approved doses for men and women, dependency risk, and how it compares to eszopiclone, zaleplon, suvorexant, and melatonin.
Read clinical review